We are live on ! Find out more
AFC

Ares Financial Consulting Portfolio holdings

AUM $139M
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
+$12.1M
Cap. Flow
+$897K
Cap. Flow %
0.64%
Top 10 Hldgs %
40.89%
Holding
1,171
New
105
Increased
235
Reduced
84
Closed
39
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACT icon
826
Enact Holdings
ACT
$6.79B
$2.92K ﹤0.01%
64
FLG
827
Flagstar Bank National Association
FLG
$5.9B
$2.9K ﹤0.01%
194
MRP
828
Millrose Properties Inc
MRP
$4.78B
$2.88K ﹤0.01%
96
AMH icon
829
American Homes 4 Rent
AMH
$12.4B
$2.88K ﹤0.01%
86
+47
+121% +$1.49K
FE icon
830
FirstEnergy
FE
$27.4B
$2.85K ﹤0.01%
60
LBRDK icon
831
Liberty Broadband Class C
LBRDK
$5.32B
$2.79K ﹤0.01%
84
UDR icon
832
UDR
UDR
$12.3B
$2.79K ﹤0.01%
70
AXS icon
833
AXIS Capital
AXS
$7.62B
$2.79K ﹤0.01%
26
TVTX icon
834
Travere Therapeutics
TVTX
$5.89B
$2.78K ﹤0.01%
+49
New +$2.17K
FMC icon
835
FMC
FMC
$1.32B
$2.78K ﹤0.01%
242
PTCT icon
836
PTC Therapeutics
PTCT
$5.91B
$2.77K ﹤0.01%
+34
New +$2.46K
BATRK icon
837
Atlanta Braves Holdings Series B
BATRK
$3.13B
$2.75K ﹤0.01%
53
AMG icon
838
Affiliated Managers Group
AMG
$9.83B
$2.71K ﹤0.01%
8
ORI icon
839
Old Republic International
ORI
$10.5B
$2.7K ﹤0.01%
66
NGVT icon
840
Ingevity
NGVT
$2.66B
$2.69K ﹤0.01%
36
MDGL icon
841
Madrigal Pharmaceuticals
MDGL
$11.8B
$2.69K ﹤0.01%
+5
New +$2.56K
SLV icon
842
iShares Silver Trust
SLV
$29.8B
$2.67K ﹤0.01%
50
ZBRA icon
843
Zebra Technologies
ZBRA
$17.2B
$2.63K ﹤0.01%
10
CUBE icon
844
CubeSmart
CUBE
$9.42B
$2.63K ﹤0.01%
66
NTB icon
845
Bank of N.T. Butterfield & Son
NTB
$2.44B
$2.62K ﹤0.01%
44
SRCE icon
846
1st Source
SRCE
$2.15B
$2.61K ﹤0.01%
32
UHAL.B icon
847
U-Haul Holding Co Series N
UHAL.B
$12.8B
$2.6K ﹤0.01%
45
LPLA icon
848
LPL Financial
LPLA
$28.3B
$2.56K ﹤0.01%
9
PRK icon
849
Park National Corp
PRK
$3.71B
$2.56K ﹤0.01%
14
LNC icon
850
Lincoln National
LNC
$8.93B
$2.51K ﹤0.01%
71

Similar funds

Ares Financial Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, Ares Financial Consulting held 1,171 positions worth $139M, up 9.5% from $127M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ares Financial Consulting's Q2 2026 filing shows 105 new, 235 increased, 84 reduced and 39 closed positions. Its largest new stake was AstraZeneca: 486 shares worth $92.2K. The largest sale was Dimensional US Core Equity Market ETF, an estimated $443K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Communication Services and Industrials.

  • Ares Financial Consulting's largest Q2 2026 buy was AstraZeneca: 486 shares worth $92.2K.
  • Ares Financial Consulting added most to PIMCO 15+ Year US TIPS Index Exchange-Traded Fund in Q2 2026, an estimated $567K increase.
  • Ares Financial Consulting's biggest Q2 2026 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $443K.
  • Ares Financial Consulting fully exited Vanguard FTSE All-World ex-US ETF in Q2 2026, selling an estimated $203K.
  • Ares Financial Consulting's ten largest holdings make up 41% of its $139M portfolio in Q2 2026.
  • Ares Financial Consulting opened 105 new positions and closed 39 in Q2 2026.
  • Ares Financial Consulting's portfolio value rose 9.5% quarter-over-quarter to $139M.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.